Company Page

Origin is a biotechnology company developing AI models for safer and more effective cell and gene therapies. The company's flagship product, Axis, is the first multifunctional AI model capable of both generating regulatory DNA elements and predicting their function, outperforming Google DeepMind's AlphaGenome on multiple benchmarks. Origin's mission is to design new biological systems and components from first principles using advanced AI architectures, creating synthetic switches and dials that program gene expression with unprecedented precision to overcome challenges in gene therapy including poor efficacy, immune responses, and off-tissue effects.

Company Founded in 2021

Healthtech & Biotech

Articles about Origin

How AI Is Redesigning DNA to Make Gene Therapy Safer

Healthtech & BiotechMar 31, 2026

Origin Bio's AI Challenges DeepMind in Gene Therapy Design

Healthtech & BiotechMar 23, 2026

AI-Designed DNA Sequences Tackle Gene Therapy Safety Crisis

Healthtech & BiotechMar 14, 2026

The AI Race to Make Gene Therapies Safer

Healthtech & BiotechMar 12, 2026

AI Designs DNA 'Switches' to Make Gene Therapies Safer

Healthtech & BiotechMar 11, 2026

AI-Designed DNA: The Race to Make Gene Therapies Safer

Healthtech & BiotechMar 5, 2026

AI Tackles Gene Therapy's Safety Crisis After Fatal FDA Warnings

Healthtech & BiotechMar 5, 2026

How AI-Designed DNA Is Making Gene Therapies Safer

Healthtech & BiotechMar 4, 2026

AI-Designed DNA Could Fix Gene Therapy's Biggest Safety Problem

Healthtech & BiotechFeb 21, 2026

How AI-Designed DNA Could Make Gene Therapy Safer

Healthtech & BiotechFeb 17, 2026